| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |